GLOW70
GLOW70 combines GHK-Cu (Copper Peptide), BPC-157 (Body Protection Compound), and TB-500 (Thymosin Beta-4 fragment) β three of the most extensively studied regenerative peptides in preclinical research, each targeting distinct repair mechanisms.
GHK-Cu modulates collagen synthesis and anti-inflammatory gene expression. BPC-157 is studied for angiogenesis, GI healing, and systemic tissue repair. TB-500 regulates actin polymerization and cellular migration. Together they target multiple regenerative pathways simultaneously.
Add 2β4mL bacteriostatic water to the GLOW70 vial. Swirl gently to dissolve all three components. Refrigerate after reconstitution; use within 28 days. Label with date of reconstitution.
Verified Before it Reaches You.
Every Genix batch undergoes independent third-party testing. The CoA for this product is batch-specific β issued by the testing laboratory, not generated by Genix.
Research Grade Β· 99% Purity
Frequently Paired With
Researchers often combine GLOW70 with these compounds for multi-target protocols.
Frequently Asked Questions
GLOW70 contains three peptides: GHK-Cu (copper peptide for collagen/repair signaling), BPC-157 (tissue healing and angiogenesis), and TB-500 (Thymosin Beta-4 fragment for actin regulation and cellular recovery).
Each targets complementary repair pathways. GHK-Cu works at gene expression level; BPC-157 promotes angiogenesis and healing signals; TB-500 supports cellular migration. Together they provide broader research coverage than any single compound.
WOLVERINE contains BPC-157 and TB-500 only. GLOW70 adds GHK-Cu, making it a triple-peptide blend that also targets skin repair, collagen synthesis, and copper-driven repair signaling.
No. All Genix compounds are strictly for in vitro research and laboratory use only. Not for human or veterinary consumption.